Global Non-Opioid Patch Supply, Demand and Key Producers, 2023-2029

Global Non-Opioid Patch Supply, Demand and Key Producers, 2023-2029

The global Non-Opioid Patch market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Non-Opioid Patch production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Non-Opioid Patch, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Non-Opioid Patch that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Non-Opioid Patch total production and demand, 2018-2029, (K Units)

Global Non-Opioid Patch total production value, 2018-2029, (USD Million)

Global Non-Opioid Patch production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-Opioid Patch consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Non-Opioid Patch domestic production, consumption, key domestic manufacturers and share

Global Non-Opioid Patch production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Non-Opioid Patch production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Non-Opioid Patch production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Non-Opioid Patch market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NEXGEL Advanced Hydrogel Solutions, Viatris Inc., Johnson and Johnson, Teva Pharmaceutical Industries Ltd, Sorrento Therapeutics Inc., Hisamitsu Pharmaceutical Co.,Inc., Endo International plc., Purdue Pharma L.P. and Amneal Pharmaceuticals LLC, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Non-Opioid Patch market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Non-Opioid Patch Market, By Region:

United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Non-Opioid Patch Market, Segmentation by Type

Prescription Medicines
OTC Medicines

Global Non-Opioid Patch Market, Segmentation by Application

Hospital Pharmacies
Drug Stores
Online Pharmacies

Companies Profiled:
NEXGEL Advanced Hydrogel Solutions
Viatris Inc.
Johnson and Johnson
Teva Pharmaceutical Industries Ltd
Sorrento Therapeutics Inc.
Hisamitsu Pharmaceutical Co.,Inc.
Endo International plc.
Purdue Pharma L.P.
Amneal Pharmaceuticals LLC
Grunenthal

Key Questions Answered

1. How big is the global Non-Opioid Patch market?

2. What is the demand of the global Non-Opioid Patch market?

3. What is the year over year growth of the global Non-Opioid Patch market?

4. What is the production and production value of the global Non-Opioid Patch market?

5. Who are the key producers in the global Non-Opioid Patch market?

6. What are the growth factors driving the market demand?